| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/30/2013 | CA2503125C Novel composition and methods for the treatment of immune related diseases |
| 04/30/2013 | CA2458995C Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 04/30/2013 | CA2435664C Ncc2705-the genome of a bifidobacterium |
| 04/30/2013 | CA2412612C Eg-vegf nucleic acids and polypeptides and methods of use |
| 04/30/2013 | CA2383154C Baff receptor (bcma), an immunoregulatory agent |
| 04/30/2013 | CA2365742C Formulations for amylin agonist peptides |
| 04/27/2013 | CA2794397A1 Modulation of ul24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection |
| 04/25/2013 | WO2013059784A1 Antigen presenting cancer vaccine |
| 04/25/2013 | WO2013059778A2 Antigen presenting cancer vaccine with gamma interferon |
| 04/25/2013 | WO2013059622A1 Treatments for mycobacterium tuberculosis |
| 04/25/2013 | WO2013059619A1 Method of treating or reducing efp |
| 04/25/2013 | WO2013059610A1 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
| 04/25/2013 | WO2013059525A1 Peptidomimetic macrocyles |
| 04/25/2013 | WO2013059496A1 Amine cationic lipids and uses thereof |
| 04/25/2013 | WO2013059491A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| 04/25/2013 | WO2013059471A1 Compositions and methods for treating leukemia |
| 04/25/2013 | WO2013059403A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of influenza virus infection |
| 04/25/2013 | WO2013059351A1 Stabilizers for hemostatic products |
| 04/25/2013 | WO2013059347A1 Methods and compositions for treating ineffective erythropoiesis |
| 04/25/2013 | WO2013059346A1 Method of forming hemostatic products |
| 04/25/2013 | WO2013059341A1 Method of forming dextran and thrombin sheets |
| 04/25/2013 | WO2013059323A1 Peg conjugates of exenatide |
| 04/25/2013 | WO2013059322A2 Amyloid beta peptide as a therapy for inflammation |
| 04/25/2013 | WO2013059320A1 Treatment of cancers with mutant npm1 with mek inhibitors |
| 04/25/2013 | WO2013059278A2 Hepatitis c virus inhibitors |
| 04/25/2013 | WO2013059234A1 Biomarkers for amyotrophic lateral sclerosis and methods using the same |
| 04/25/2013 | WO2013059232A1 Methods and compositions for the management of cancer using 2-dg and an igf-ir inhibitor |
| 04/25/2013 | WO2013059213A1 Chemically and thermodynamically stable insulin analogues and improved methods for their production |
| 04/25/2013 | WO2013059071A1 Aromatic-cationic peptides and uses of same |
| 04/25/2013 | WO2013058833A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| 04/25/2013 | WO2013057599A1 Biomarker |
| 04/25/2013 | WO2013057219A1 Method for improving the stability of purified factor viii after reconstitution |
| 04/25/2013 | WO2013057171A1 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii |
| 04/25/2013 | WO2013057167A1 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii |
| 04/25/2013 | WO2013056657A1 Activity-enhanced l-asparaginase variant |
| 04/25/2013 | WO2013056501A1 Compositions and methods for quantitative detection of microorganisms and cells |
| 04/25/2013 | WO2013056453A1 Preparation method and application of injection for needleless injection |
| 04/25/2013 | WO2013056372A1 Peptide compounds derived from melanotransferrin and uses thereof |
| 04/25/2013 | WO2013056309A1 Novel plant defensins and use in the treatment of proliferative diseases |
| 04/25/2013 | WO2013056308A1 Novel forms of plant defensins |
| 04/25/2013 | WO2013033636A3 Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same |
| 04/25/2013 | WO2013033452A3 Fgf21 for use in treating type 1 diabetes |
| 04/25/2013 | WO2013033366A3 Methods and compositions for promoting glucose homeostasis |
| 04/25/2013 | WO2013025474A9 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 04/25/2013 | WO2013022982A3 Pegylated tyrosyl-trna synthetase polypeptides |
| 04/25/2013 | WO2013019923A3 Methods for detecting progenitor cells and uses thereof |
| 04/25/2013 | WO2013016297A3 Tumor selective chemokine modulation |
| 04/25/2013 | WO2012177444A3 Glucagon/glp-1 receptor co-agonists |
| 04/25/2013 | WO2012177443A3 Glucagon/glp-1 receptor co-agonists |
| 04/25/2013 | WO2012138927A3 Method for the generation of compact tale-nucleases and uses thereof |
| 04/25/2013 | WO2012021512A8 Erythrocyte-binding therapeutics |
| 04/25/2013 | WO2012016216A3 Assays for detection of glycosaminoglycans |
| 04/25/2013 | WO2011163512A3 Cancer therapy |
| 04/25/2013 | US20130102769 Interfering rna molecules |
| 04/25/2013 | US20130102757 Methods for selective targeting |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/25/2013 | US20130102656 Use of a granulin or a granulin-like compound for the therapy or prophylaxis of chronic pain |
| 04/25/2013 | US20130102633 Transglutaminase inhibitors and methods of use thereof |
| 04/25/2013 | US20130102545 Temperature dependent activation of catalytic nucleic acids for controlled active substance release |
| 04/25/2013 | US20130102544 Disease-Associated Proteins |
| 04/25/2013 | US20130102543 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 04/25/2013 | US20130102542 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets |
| 04/25/2013 | US20130102541 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 04/25/2013 | US20130102538 Method of treating alzheimer's disease using pharmacological chaperones to increase presenilin function and gamma-secretase activity |
| 04/25/2013 | US20130102537 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 04/25/2013 | US20130102536 Compositions and methods for modulating toll-like receptor 2 activation |
| 04/25/2013 | US20130102535 Method for Preventing Myocardial Ischemia |
| 04/25/2013 | US20130102534 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 04/25/2013 | US20130102532 HB-EGF Composition and Use Thereof to Treat a Condition Associated With Enhanced Urothelium Permeability |
| 04/25/2013 | US20130102530 Protection, Restoration and Enhancement of Erythropoietin-Responsive Cells, Tissues and Organs |
| 04/25/2013 | US20130102528 Methods and Pharmaceutical Composition for the Treatment of a Feeding Disorder with Early-Onset in a Patient |
| 04/25/2013 | US20130102527 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
| 04/25/2013 | US20130102526 Methods for Treating HCV |
| 04/25/2013 | US20130102525 Methods for Treating HCV |
| 04/25/2013 | US20130102523 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
| 04/25/2013 | US20130102521 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |
| 04/25/2013 | US20130101671 Polypeptide for treating or preventing adhesions |
| 04/25/2013 | US20130101659 Cell sheet for myocardial regeneration, method of producing the same, and method of using the same |
| 04/25/2013 | US20130101641 Periodontal Regeneration Composition and Method of Using Same |
| 04/25/2013 | US20130101634 Compositions and methods for reducing microbial overgrowth in the small intestines |
| 04/25/2013 | US20130101615 Methods for preventing or treating a disease or condition associated with mycobacterium avium subspecies paratuberculosis |
| 04/25/2013 | US20130101611 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity |
| 04/25/2013 | US20130101610 Therapeutic Uses of CD137 in Treating Autoimmune Disease |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101577 Extended Soluble PH20 Polypeptides and uses thereof |
| 04/25/2013 | US20130101575 Lactoferrin seqences, compositions and methods for corneal wound treatment |
| 04/25/2013 | US20130101574 Methods of using thrombin peptide derivatives |
| 04/25/2013 | US20130101573 Degradation resistant hsp70 formulations and uses thereof |
| 04/25/2013 | US20130101572 Compositions and methods for treatment of vitiligo |
| 04/25/2013 | US20130101571 Antidotes for nitrobenzodiazepines |
| 04/25/2013 | US20130101565 Use of carbonic anhydrase ii for producing a drug |
| 04/25/2013 | US20130101554 Therapeutic regimen comprising peg-interferon, ribavirin and vx-950 for the treatment of hepatitis |
| 04/25/2013 | US20130101552 Methods and compositions for contributing to the treatment of cancers |
| 04/25/2013 | US20130101550 Product and method for permeabilisation of tumor vasculature |
| 04/25/2013 | US20130101510 Methods of treating parkinson's disease using viral vectors |
| 04/25/2013 | US20130098357 Cerivastatin to treat pulmonary disorders |
| 04/25/2013 | DE4420157B4 Neuer Wachstums/Differenzierungsfaktor der TGF-β-Familie New growth / differentiation factor TGF-β family |
| 04/25/2013 | CA2854294A1 Method of forming dextran and thrombin sheets |
| 04/25/2013 | CA2852967A1 Antigen presenting cancer vaccine |